NM_001366385.1:c.526G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001366385.1(CARD14):​c.526G>C​(p.Asp176His) variant causes a missense change. The variant allele was found at a frequency of 0.00136 in 1,583,302 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 19 hom. )

Consequence

CARD14
NM_001366385.1 missense

Scores

8
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.19

Publications

27 publications found
Variant links:
Genes affected
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
CARD14 Gene-Disease associations (from GenCC):
  • familial pityriasis rubra pilaris
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • psoriasis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0063112676).
BP6
Variant 17-80184089-G-C is Benign according to our data. Variant chr17-80184089-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 527891.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00187 (285/152366) while in subpopulation EAS AF = 0.0193 (100/5182). AF 95% confidence interval is 0.0162. There are 1 homozygotes in GnomAd4. There are 175 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 285 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD14NM_001366385.1 linkc.526G>C p.Asp176His missense_variant Exon 7 of 24 ENST00000648509.2 NP_001353314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD14ENST00000648509.2 linkc.526G>C p.Asp176His missense_variant Exon 7 of 24 NM_001366385.1 ENSP00000498071.1 Q9BXL6-1

Frequencies

GnomAD3 genomes
AF:
0.00188
AC:
286
AN:
152248
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0194
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.0114
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000808
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00290
AC:
569
AN:
196074
AF XY:
0.00284
show subpopulations
Gnomad AFR exome
AF:
0.0000856
Gnomad AMR exome
AF:
0.0000354
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0189
Gnomad FIN exome
AF:
0.0101
Gnomad NFE exome
AF:
0.00103
Gnomad OTH exome
AF:
0.00336
GnomAD4 exome
AF:
0.00130
AC:
1866
AN:
1430936
Hom.:
19
Cov.:
31
AF XY:
0.00129
AC XY:
914
AN XY:
708932
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32948
American (AMR)
AF:
0.00
AC:
0
AN:
39422
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25450
East Asian (EAS)
AF:
0.0203
AC:
776
AN:
38208
South Asian (SAS)
AF:
0.000440
AC:
36
AN:
81902
European-Finnish (FIN)
AF:
0.0101
AC:
510
AN:
50616
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5728
European-Non Finnish (NFE)
AF:
0.000405
AC:
444
AN:
1097426
Other (OTH)
AF:
0.00165
AC:
98
AN:
59236
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
102
204
307
409
511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00187
AC:
285
AN:
152366
Hom.:
1
Cov.:
33
AF XY:
0.00235
AC XY:
175
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41590
American (AMR)
AF:
0.0000653
AC:
1
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0193
AC:
100
AN:
5182
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4832
European-Finnish (FIN)
AF:
0.0114
AC:
121
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000808
AC:
55
AN:
68032
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000752
Hom.:
0
Bravo
AF:
0.000945
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00249
AC:
300
Asia WGS
AF:
0.0100
AC:
35
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 28, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autoinflammatory syndrome Benign:1
Nov 01, 2017
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.40
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.023
T;T;.;T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.79
.;.;T;T
MetaRNN
Benign
0.0063
T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.5
M;M;M;M
PhyloP100
5.2
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.73
.;.;.;N
REVEL
Benign
0.081
Sift
Benign
0.032
.;.;.;D
Sift4G
Uncertain
0.0070
D;.;D;D
Polyphen
0.99
D;D;.;D
Vest4
0.25
MVP
0.73
MPC
0.62
ClinPred
0.052
T
GERP RS
3.6
Varity_R
0.15
gMVP
0.26
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144475004; hg19: chr17-78157888; API